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ABSTRACT
Firstly described in the 19th century by Sir William Osler, the mycotic aneurysm (MA) is a rare entity characterized by 
an abnormal arterial dilation, which is potentially fatal, and is associated with the infection of the vascular wall. Elderly 
patients are mostly involved, especially when risk factors like chronic diseases, immunosuppression, neoplasia, and arterial 
manipulation are associated. The authors report the case of a young male patient diagnosed with an aortic aneurysm 
of infectious origin in the presence of repeated negative blood cultures. The diagnostic hypothesis was raised when 
the patient was hospitalized for an inguinal hernia surgery. The diagnosis was confirmed based on imaging findings 
consistent with mycotic aneurism. The patient was treated with an endovascular prosthesis associated with a long-lasting 
antibiotic therapy. Five months later, the patient attended the emergency unit presenting an upper digestive hemorrhage 
and shock, from which he died. The autopsy revealed a huge aneurysm of the abdominal aorta with an aortoduodenal 
fistula. The histological examination of the arterial wall revealed a marked inflammatory process, extensive destruction 
of the arterial wall, and the presence of Gram-positive bacteria. This case highlights the atypical presentation of a MA 
associated with an aortoduodenal fistula. Besides the early age of the patient, no primary arterial disease could be found, 
and no source of infection was detected. 
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CASE REPORT
A 23-year-old man sought emergency care 
complaining of a 2-month history of a burning 
mesogastric pain irradiating to the lumbar region 
that worsened on the palpation of the right flank. 
On the tenth postoperative day of an elective right 
inguinal hernioplasty, an abdominal pulsatile mass 
was detected. The hernioplasty was indicated before 
the abdominal symptoms started and preoperative 
lab work-up did not reveal abnormalities such as 
leukocytosis. The patient was advised to proceed with 
further investigation, but he refused.
Due to the worsening of his abdominal pain, he 
sought medical assistance in a hospital emergency 
department on the 10 th post-operat ive day. 
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On admission, the physical examination revealed a 
well-looking patient, slightly pale with normal vital 
signs, emaciated (the patient mentioned a weight loss 
of 10 kg over the past 2 months), and was afebrile. 
The abdominal palpation depicted a painful pulsatile 
mass in the mesogastrium, and on auscultation there 
was a bruit in the same region. No signs of peritoneal 
irritation were found. The patient denied drug 
addiction and did not recall any infections over recent 
months. The search for Koch’s bacillus in sputum and 
urine was negative, and the patient’s epidemiology was 
not conducive to tuberculosis. VDRL and ELISA tests 
were negative and excluded syphilis and HIV infection, 
respectively.
The aortic angiogram computed tomography 
(CT) revealed an infrarenal aortic saccular aneurysm 
measuring 6.7 × 5.2 cm (Figure 1).
The aneurysm presented irregular contours and 
ulcerations, and was surrounded in its entire extension 
by an irregular dense tissue with fat tissue obliteration 
(Figure 2A). The aneurysm anteriorly displaced the 
duodenum and laterally the inferior vena cava and 
the iliac veins (Figure 2B). The CT findings were 
consistent with a mycotic aneurysm (MA). The patient 
was hospitalized and submitted to an endovascular 
treatment which consisted of the implantation of 
an aorto-bi-iliac endovascular stent associated with 
long-lasting empiric antibiotic therapy, which comprised 
oxacillin and ceftriaxone. A blood culture was sampled 
before the procedure, but the result was negative. 
An abdominal CT was undertaken and the patient was 
discharged clinically well and afebrile, four days after 
the procedure.
Over the next 3 months, the patient was 
hospitalized two more times. At each admission, he 
was in poor clinical condition, febrile, and presented 
abdominal pain. He was prescribed vancomycin, 
meropenem, and micafungin. Blood cultures were 
repeatedly negative (including anaerobic cultures) 
and continuing transthoracic and transesophageal 
echocardiograms were normal.
During his third hospitalization, the patient 
received 35 days of antimicrobial therapy, ran out of 
fever and refused to remain longer in the hospital. 
After 2 months he returned to the emergency 
Figure 1. Aortic angiogram CT revealed an infrarenal 
aortic saccular aneurysm measuring 6.7 × 5.2 cm (arrow).
Figure 2. Abdominal CT. A (sagittal plane) - Infrarenal aortic saccular aneurysm presenting irregular contours, ulceration, 
surrounded by irregular dense tissue (arrow); B (axial plane) - The anterior displacement of the duodenum (arrow).
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facility complaining of severe and diffuse abdominal 
pain followed by upper digestive hemorrhage and 
hypovolemic shock. The abdominal CT revealed the 
presence of thrombi throughout the entire aorta and 
gaseous foci within the endoprosthesis indicating 
the presence of an aortoenteric fistula (Figure 3). 
Unfortunately, the patient died 1 day after hospital 
admission. An autopsy was performed with an 
informed consent signed by the family.
AUTOPSY FINDINGS
The autopsy examination revealed the presence 
of a huge abdominal aortic aneurysm measuring 
7.0 cm in extension and 5.0 cm in diameter filled 
in by an aortoiliac prosthesis, which was extensively 
thrombosed (Figure 4A). The aortic wall presented 
a local ulceration that extended towards the third 
duodenal portion producing an aortoenteric fistula 
(Figure 4B), which was responsible for the massive 
intestinal bleeding.
The histological examination of this area revealed 
a marked transmural inflammatory process with an area 
of destruction of the aorta wall, which was replaced 
by fibrosis (Figure 5A) and with suppurative areas in 
the wall of the fistula track and periaortic soft tissues 
(Figure 5B). The remaining aorta wall had no evidence 
of inflammatory or degenerative disease (Figure 5C). 
Verhoeff stain was performed (Figure 5D) as well as 
an immunohistochemical study to characterize the 
inflammatory component and exclude the possibility 
of immunoglobulin (Ig)G4 related disease (CD3, CD20, 
CD68, CD138, IgG, and IgG4) as well as other aortic 
vasculitis.
The Brown-Hopps stain revealed the presence 
of pleomorphic Gram-positive bacilli (Figure 6). 
Unfortunately, a culture of the aortoenteric fistula’s 
tissue was not collected during the autopsy examination. 
The left iliac artery communicated with an inguinal 
abscess, which was interpreted as a metastatic 
manifestation of the MA. The heart weighted 340 g, 
Figure 3. Abdominal CT prior to death. A - (axial plane) Gaseous focus within the endoprosthesis (arrow) indicating 
aortoenteric fistula; B - (sagittal plane) The presence of thrombi throughout the aortoiliac endoprosthesis (arrow).
Figure 4. Macroscopic view. A - Segment of abdominal 
aorta with an aneurysm of 7.0 × 5.0 cm with the lumen 
filled in by an aortoiliac prosthesis. Note extensive mural 
thrombosis; B - Third duodenal portion in close relation 
to the abdominal aneurysm presenting an aorto-enteric 
fistula covered by blood clots.
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(reference value [RV]: 350 g) and was normal. The 
cardiac valves were thin and translucent, without any 
evidence of actual or previous endocarditis. No other 
organ alteration was observed except for evidence of 
bronchopneumonia.
DISCUSSION
In 1885, Sir William Osler first use the term “mycotic 
aneurysm” describing the autopsy of a 30-year-old man 
who died after presenting diarrhea, chills, cephalea, 
cough, and fever. In this autopsy, he found the aortic 
valve extensively destroyed by a vegetation as well as 
four aneurysms of the aortic arch with evidence of 
endocarditis and mycotic endarteritis.1 Currently, the 
“mycotic” term is used to describe all the infected 
aneurysms regardless of the etiological agent.2,3
MA is a rare entity, occurring in 0.9% of a 
series comprising 2,585 patients treated for arterial 
aneurysms.4 MA has been observed in different 
age groups including newborns. However, they 
are much more prevalent in elderly patients with 
Figure 5. A - Panoramic view of the aorta with the fistula track showing the destruction of arterial wall (H&E 0.45X); 
B - Periaortic soft tissues infiltrated by inflammatory cells presenting suppurative areas and the fistulous track with 
hemorrhagic evidence remaining in its light (H&E 9.84X); C - Photomicrography of the aorta showing a segment of 
the aorta close to the perforation area without pathological alterations (H&E 3.29X); D - Verhoeff staining showing 
the area of destruction of the aorta wall, which was replaced with fibrosis (Verhoeff 1.61X).
Figure 6. A & B - Photomicrographs of the aneurysm wall showing pleomorphic Gram-positive bacilli (Brown-
Hopps, 1000X).
Vitturi BK, Frias A, Sementilli R, Racy MCJ, Caffaro RA, Pozzan G
31Autops Case Rep (São Paulo). 2017;7(2):27-34
atherosclerosis.2,5 The epidemiology of this entity is 
changing. In the past, the infectious endocarditis 
represented the main cause of MA; however, currently, 
with the availability of the antibiotic therapy, this 
relationship occurs in the minority of the cases.6-8 
The main risk factor for the development of MA are: 
(i) arterial catheterization; (ii) previous surgeries 
in distant sites; (iii) immunosuppression due to 
chronic diseases; (iv) neoplasia; (v) use of corticoids 
or other cytotoxic agents; (vi) drug addiction; and 
(vii) hemodialysis.4,5 Salmonella spp. and Staphylococcus 
spp. are the main etiological agents related to MA.6-8
Intriguingly, our patient was young without a 
known risk factor, and no etiological agent could be 
isolated. The syphilis, HIV, and TB tests were negative. 
Autoimmune aortitis (e.g. Takayasu’s arteritis) was 
excluded since the patient did not present compatible 
clinical aspects, and the postmortem histological 
examination did not reveal pathological changes in 
other sites of the aorta and in other vessels. Also, the 
patient had no primary vascular disease. Nevertheless, 
the patient could have had a subclinical and unnoticed 
bacteremia, which could have been the source for the 
MA development. Although the patient denied drug 
addiction, this is information was not entirely credible.
The primary source of infection may be identified 
in 86% of the patients with abdominal MA.9,10 Upper 
airway infections, cellulitis, osteomyelitis, pneumonia, 
urinary tract infections, and non-healed wounds have 
been described.5
MA may be the result of an infection of the arterial 
wall, or it may rise as an infection of a previously 
formed aneurysm.11 The microorganisms generally 
colonize the vessel by embolization, extension of 
an adjacent suppurative process, or circulation of 
viable micro-organisms within the arterial wall during 
bacteremia. Depending on the virulence of the 
etiological agent and the blood pressure, the growth of 
the aneurysm may be fast, reaching centimeters within 
a month.5 The vessels with congenital abnormalities 
(aortic coarctation, patent ductus arteriosus) or 
vessels with atherosclerosis are more prone for the 
development of MA.2,12,13 In our case, we believe 
that the MA was formed before the hernioplasty. 
The fact that the patient’s symptoms started 2 months 
before the inguinal surgery, and that a pulsatile mass 
could be palpable before the procedure supports 
the previous existence of the aneurysm. It is unlikely 
that the aneurysm was present and became infected 
after the hernioplasty, since the patient was very 
young for having an aneurysm, and a primary 
vascular disease was not found on the autopsy. 
Moreover, the CT and angiogram images, performed 
10 days after the surgery, were consistent with an 
infectious aneurysm. It was unclear why the aneurysm 
might not have been detected at the time of the 
hernioplasty. This elapsed time is insufficient for a 
MA to be developed. However, the patient’s data and 
images suggest that he might have had an intermittent 
bowel obstruction due to intestinal incarceration in 
his inguinal hernia and at some point, Gram-positive 
bacteria got into the bloodstream and could have 
contributed to the development of the MA.
In contrast to the case reported herein, etiology is 
frequently confirmed. In a study comprising 109 patients 
with MA,14 101 cases rendered a positive culture. In our 
case, bacteria identified in the histological examination 
with the aid of the Brown-Hopps staining were all 
Gram-positive and pleomorphic, which suggests that 
the infection was polymicrobial, presumably with 
multiple types of anaerobic bacilli from the gut.
MA may be found in any artery. However, they 
are more frequently found in different aortic portions 
(arch, thoracic, thoracoabdominal, and superior 
abdominal) and in the great aortic branches, as 
observed in our patient.4,5,15-17
The symptoms of the MA are mostly non-specific, 
reflecting the insidious nature of the disease.18,19 
However, when present, they are predominantly 
represented by fever; abdominal, lumbar or thoracic 
pain; chills; and the presence of a pulsatile mass.20,21 
Hence, an imaging exam is crucial for the diagnosis, 
and CT is the method most often used. The imaging 
findings that favor the diagnosis of MA are: (i) atypical 
localization of the aneurysm: (ii) lack of calcium within 
the vessel wall; (iii) multilobular aspect; (iv) multifocal 
or saccular configuration; (v) presence of periaortic gas; 
(vi) adjacent soft tissue reaction; and (vii) simultaneous 
presence of osteomyelitis.5 The CT findings of our 
patient favored the diagnosis of MA because of the 
unusual site of an aneurysm, the early age of onset, 
the presence of irregular contour, the thickening of 
the vessel wall, the fat tissue obliteration, and the 
displacement of the duodenum, inferior vena cava, 
and iliac veins.
The treatment of choice for the MA is not a 
consensus and varies according to the anatomic 
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localization and severity of the infection. However, the 
therapy generally consists of a surgical approach and 
long-term antibiotic therapy.
In this setting, the surgical approach for patients 
with the diagnosis of MA presents a high index 
of mortality, mainly when associated with other 
comorbidities that substantially increase the surgical 
risk.13,22,23
Revascularization with aortic exclusion has 
been a widely performed technique with a survival 
rate of 61%. However, revascularization with the 
in situ graft insertion, following the resection and 
debridement of the involved surrounding infected 
tissue, presents a survival rate of 75%.22 As MA is a 
rare disease, experience with its surgical management 
is not extensive and varies from hospital to hospital.2 
Mortality rates can reach 48% regardless of the 
surgical treatment chosen.2 If, on the one hand, there 
are controversies about how the surgical intervention 
should be performed, on the other hand it is mandatory 
to remove the infected material.2,22
More recently, other studies showed that the 
endovascular repair technique is an important 
alternative for MA treatment. It works as damage 
control and facilitates the subsequent effective open 
surgery.22 In our case, the endovascular treatment 
was performed because of the understanding that an 
aneurysmectomy and an open approach would present 
an increased risk, and the patient had high chances of 
dying during the procedure. Furthermore, a femoral 
vein graft and an aortic ligation with extra-anatomical 
repair could not withstand the aortic pressure, mainly 
because they would have to be large and resistant 
enough. Reconstruction with a conserved corpse aorta 
from an aorta bank and using a Dacron prosthesis 
associated with chemotherapy and coverage of 
biological material are alternatives to MA treatment, 
but they also represent difficult options.2 Also, the 
material can be easily infected again, or can be rejected 
by the patient’s immune system and chemotherapy 
could worsen the patient’s clinical condition. The poor 
prognosis of this entity is frequently associated with 
sepsis and the rupture of the aneurysm.5,24
The aorto-duodenal fistula (ADF) is a rare and 
potentially fatal complication with the incidence 
ranging between 0.04% and 0.07%, in autopsies.25-27 
It is defined as an abnormal communication between 
the aorta and the duodenum, and is classified in 
primary when associated with aneurysms, and 
secondary when related to surgical procedures—the 
occurrence of which is 10 times more frequent.28 
The third duodenal portion is more often involved since 
it is localized in the retroperitoneum in close contact 
with the aorta.29,30 It is most likely that our patient’s 
case is an example of secondary ADF, since it developed 
after the endovascular repair and next to the top edge 
of the graft. Also, the relation between aortic grafting 
and aortoenteric fistulas is well established.29,30
The clinical features of ADF are: (i) gastrointestinal 
bleeding (64%); (ii) abdominal pain (32%); and (iii) the 
presence of a pulsatile mass (25%).31-33 Generally, the 
patients present self-limited gastrointestinal bleeding 
(sentinel bleeding) followed by massive bleeding. 
The principal diagnostic examination is the angiogram 
CT that presents sensitivity ranging from 40% to 90% 
and specificity from 33% to 100%.33,34 However, 
given the frequent sudden onset of the digestive 
hemorrhage, imaging exams and an endoscopic 
examination are not always feasible. If there is time for 
any therapy, the surgical approach is recommended. 
The mortality rate is 100% without any therapeutic 
modality due to hypovolemic shock.35,36 Femoral artery 
pseudoaneurysms (FAP) occur when a blood vessel wall 
is injured and the blood is contained by the surrounding 
tissues. FAPs are mostly described in drug addicted 
or immunosuppressed patients. The main etiologies 
involve trauma, vessel wall infection, surgeries, and 
endovascular procedures.37-39 Ultrasound is the most 
common method to diagnose FAPs.37 In our case, we 
believe that the infectious process associated with the 
endovascular intervention were responsible for the 
FAP. The treatment is controversial, but open surgical 
repair represents a very high risk option, and arterial 
ligation tends to be the most indicated procedure, 
which was the case with our patient.38,39
CONCLUSION
We report an atypical case of MA that evolved 
with an aortoduodenal fistula—a rare complication. 
We highlight the early age of the patient, the absence 
of predisposing factors, the less common site of 
the aneurysm, and the persistent negative blood 
cultures. An MA is a rare entity that may exhibit 
varied presentations, which challenges its diagnosis. 
Aortoenteric fistulas are rare, but their suspicion should 
be raised as a possible complication of MA.
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